A western blot for phospho-BCR-ABL1 and phospho-CRKL, a downstream adapter protein that functions as a prognostic indicator in patients with CML [46], was performed. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.